LncRNA SRA gene polymorphisms and risk of gynecological pathology development among Ukrainian women with proliferative type of benign breast disease without atypia

Authors

DOI:

https://doi.org/10.14739/2310-1210.2021.5.230144

Keywords:

breast disease, lncRNA, SRA, single nucleotide polymorphism

Abstract

Benign breast disease is a group of all noncancerous mammary lesions with a risk of breast cancer (BC) development. BC is the most common cancer in the world; therefore, it is necessary to find new biomarkers and targets for early diagnosis, treatment, prediction of prognosis and survival. Long non-coding RNA SRA could play this role, thus further studies of its impact on the precancerous lesion pathogenesis are needed.

The aim. To analyze the association between SRA1 rs801460 and rs10463297 SNPs and the occurrence of gynecological pathology among Ukrainian women with the proliferative type of benign breast disease without atypia.

Materials and methods. This study included 115 patients with proliferative type of benign breast disease without atypia: 55 – with gynecological pathology and 60 – without it. Polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP) was used for polymorphism genotyping.

Hematoxylin and eosin, toluidine blue and van Gieson’s picrofuchsin methods were applied for staining of sections. Statistical analysis was carried out using Statistical Package for the Social Sciences software (SPSS, version 25.0, Chicago, IL, USA).

Results. Significant differences were found in the rs10463297 frequency of alleles (P = 0.032), but not in the rs801460 (P > 0.05), in groups with and without gynecological pathology, while the distribution of both single nucleotide polymorphism (SNPs) genotypes was similar between these groups (P > 0.05). Statistically significant association was detected between SRA1 rs10463297 polymorphism and gynecological pathology occurrence in both dominant (Pa = 0.023; ORa = 2.638, 95 % CI = 1.145–6.076) and additive (Pa = 0.034; ORa = 2.489, 95 % CI = 1.069–5.794) models of inheritance.

No association was found between SRA1 rs801460 SNP and gynecological pathology development among Ukrainian women with proliferative type of benign breast disease without atypia (P > 0.05).

Conclusions. It was revealed that SRA1 rs10463297 TT carriers had 2.6 times higher risk of gynecological pathology development than C allele carriers and 2.48 times than TC carriers.

Author Biographies

I. M. Lukavenko, Sumy State University, Sumy, Ukraine

MD, PhD, Assistant of the Department of Surgery, Traumatology, Orthopedics and Phthisiology

A. V. Kolnoguz, Sumy State University, Sumy, Ukraine

medical student

V. Yu. Harbuzova, Sumy State University, Sumy, Ukraine

PhD, DSc, Professor of the Department of Physiology and Pathophysiology with Medical Biology Course

O. V. Ataman, Sumy State University, Sumy, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Physiology and Pathophysiology with Medical Biology Course

References

Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., Xue, C., Marinov, G. K., Khatun, J., Williams, B. A., Zaleski, C., Rozowsky, J., Röder, M., Kokocinski, F., Abdelhamid, R. F., Alioto, T., … Gingeras, T. R. (2012). Landscape of transcription in human cells. Nature, 489(7414), 101-108. https://doi.org/10.1038/nature11233

Sanchez Calle, A., Kawamura, Y., Yamamoto, Y., Takeshita, F., & Ochiya, T. (2018). Emerging roles of long non-coding RNA in cancer. Cancer Science, 109(7), 2093-2100. https://doi.org/10.1111/cas.13642

Chi, Y., Wang, D., Wang, J., Yu, W., & Yang, J. (2019). Long Non-Coding RNA in the Pathogenesis of Cancers. Cells, 8(9), Article 1015. https://doi.org/10.3390/cells8091015

Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2018). Non-coding RNA networks in cancer. Nature Reviews Cancer, 18(1), 5-18. https://doi.org/10.1038/nrc.2017.99

Lanz, R. B., McKenna, N. J., Onate, S. A., Albrecht, U., Wong, J., Tsai, S. Y., Tsai, M. J., & O'Malley, B. W. (1999). A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex. Cell, 97(1), 17-27. https://doi.org/10.1016/s0092-8674(00)80711-4

Leygue, E. (2007). Steroid Receptor RNA Activator (SRA1): Unusual Bifaceted Gene Products with Suspected Relevance to Breast Cancer. Nuclear Receptor Signaling, 5(1), Article e006. https://doi.org/10.1621/nrs.05006

Lanz, R. B., Chua, S. S., Barron, N., Söder, B. M., DeMayo, F., & O'Malley, B. W. (2003). Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo. Molecular and Cellular Biology, 23(20), 7163-7176. https://doi.org/10.1128/MCB.23.20.7163-7176.2003

Clarke, R. B. (2004). Human breast cell proliferation and its relationship to steroid receptor expression. Climacteric, 7(2), 129-137. https://doi.org/10.1080/13697130410001713751

Sheng, L., Ye, L., Zhang, D., Cawthorn, W. P., & Xu, B. (2018). New Insights Into the Long Non-coding RNA SRA: Physiological Functions and Mechanisms of Action. Frontiers in Medicine, 5, Article 244. https://doi.org/10.3389/fmed.2018.00244

Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin, K. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Research, 29(1), 308-311. https://doi.org/10.1093/nar/29.1.308

Calhoun, B. C., Grobmyer, S. R., & Simpson, J. F. (2018). 8 - Benign, High-Risk, and Premalignant Lesions of the Breast. In K. I. Bland, E. M. Copeland, V. S. Klimberg & W. J. Gradishar (Eds.), The Breast (pp. 116-129.e3). Elsevier. https://doi.org/10.1016/b978-0-323-35955-9.00008-8

International Agency for Research on Cancer. (n.d.). CANCER TODAY. Data visualization tools for exploring the global cancer burden in 2020. https://gco.iarc.fr/today/home

Sasaki, J., Geletzke, A., Kass, R. B., Klimberg, V. S., Copeland, E. M., & Bland, K. I. (2018). 5 - Etiology and Management of Benign Breast Disease. In K. I. Bland, E. M. Copeland, V. S. Klimberg & W. J. Gradishar (Eds.), The Breast (pp. 79-92.e5). Elsevier. https://doi.org/10.1016/b978-0-323-35955-9.00005-2

Yan, R., Wang, K., Peng, R., Wang, S., Cao, J., Wang, P., & Song, C. (2016). Genetic variants in lncRNA SRA and risk of breast cancer. Oncotarget, 7(16), 22486-22496. https://doi.org/10.18632/oncotarget.7995

Tan, J., Hao, X., Zhao, T., Ying, J., Li, T., & Cheng, L. (2020). Association between long-chain non-coding RNA SRA1 gene single-nucleotide polymorphism and polycystic ovary syndrome susceptibility. Journal of Assisted Reproduction and Genetics, 37(10), 2513-2523. https://doi.org/10.1007/s10815-020-01922-3

Downloads

Published

2021-09-01

How to Cite

1.
Lukavenko IM, Kolnoguz AV, Harbuzova VY, Ataman OV. LncRNA SRA gene polymorphisms and risk of gynecological pathology development among Ukrainian women with proliferative type of benign breast disease without atypia. Zaporozhye Medical Journal [Internet]. 2021Sep.1 [cited 2024Dec.12];23(5):651-5. Available from: http://zmj.zsmu.edu.ua/article/view/230144

Issue

Vol. 23 No. 5 (2021)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)